First published 10/1/2026, 10:35:15 PM · Last updated 10/1/2026, 10:35:15 PM

Prevalence and Antibiotic Resistance Profile of Secondary Bacterial Pneumonia and Bloodstream Infections Among Hospitalized COVID-19 Patients and Their Relation to Procalcitonin

Journal article reporting the prevalence and antibiotic resistance profile of secondary bacterial pneumonia and bloodstream infections among hospitalized COVID-19 patients and their relation to procalcitonin. Published 2023-09-01; the supplied excerpt includes only publisher metadata and provides no study details.

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 3/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 1/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 2/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The study concerns antibiotic resistance and the relation of procalcitonin to secondary infections in hospitalized COVID-19 patients.

Sources

Prevalence and Antibiotic Resistance Profile of Secondary Bacterial Pneumonia and Bloodstream Infections Among Hospitalized COVID-19 Patients and Their Relation to Procalcitonin

Report an issue